| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 16,614 | 12,404 | 10,030 | | Cost of Revenue | 15,875 | 14,474 | 10,121 | | | Gross Profit | 739 | (2,070) | (91) | | | Operating Expenses | | Research Development | 1,372 | 1,198 | 3,571 | | Selling General and Administrative | 8,722 | 11,811 | 12,607 | | Non Recurring |
-
|
-
| 2,091 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,355) | (15,079) | (18,360) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 637 | 1,418 | 813 | | Earnings Before Interest And Taxes | (8,718) | (13,661) | (17,547) | | Interest Expense | 2 | 3 | 13 | | Income Before Tax | (8,720) | (13,664) | (17,560) | | Income Tax Expense |
-
|
-
| (46) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,720) | (13,664) | (17,514) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,720) | (13,664) | (17,514) | | Preferred Stock And Other Adjustments | (4,208) | (1,180) | (1,200) | | | Net Income Applicable To Common Shares | ($12,927) | ($14,844) | ($18,714) |
|
0.02% Nasdaq 
0.33%
Income Statement
